Ocata Therapeutics Appoints John Heffernan, Vice President Of Manufacturing

Ocata Therapeutics, Inc. (“Ocata”; OTCBB: OCAT), a leader in the field of regenerative ophthalmology, today announced the appointment of John Heffernan, a pharmaceutical industry veteran, to the newly created position of Vice President of Manufacturing. Mr. Heffernan has a breadth of experience in all facets of manufacturing in the cell therapy space.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC